ストックスクリーナーアプリを入手
2.39
2.14%
0.05
Tuhura Biosciences Inc (HURA) 最新ニュース
Form DEF 14A TuHURA Biosciences For: 9 July By Investing.com - Investing.com Nigeria
TuHURA Biosciences, Inc. (NASDAQ: HURA) Files 8-K Report Detailing Company Information and Compliance Updates – Minichart - Minichart
TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks
TuHURA Biosciences names Amanda Garofalo as clinical operations SVP - Investing.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Dynamic Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000E Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Completeness Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2500 Index - marketscreener.com
Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – FWB:PL3 - TradingView
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000 Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Enterprise value to EBITDA forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView
EBITDA per share of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Price to earnings forward of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Cash per share of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Return on equity % of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Enterprise value to revenue forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView
Net income before discontinued operations of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
TuHURA Biosciences, Inc. Balance Sheet – DUS:PL3 - TradingView
Form PRE 14A TuHURA Biosciences For: 26 June By Investing.com - Investing.com Nigeria
TuHURA Biosciences (HURA) virtual annual meeting Aug 18; shareholders to vote on 1.88M-share issuance - Stock Titan
TuHURA Biosciences, Inc. Actuals & Estimates (NASDAQ:HURA) - TradingView
TuHURA Biosciences, Inc. Actuals & Estimates (MUN:PL3) - TradingView
HURA Forecast — Price Target — Prediction for 2027 - TradingView
PL3 Forecast — Price Target — Prediction for 2027 - TradingView
TuHURA Biosciences (HURA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
TuHURA Biosciences (HURA) Dips 4.55% as Shares Approach Key Support LevelLate Stage Breakouts - dars.gov.et
TuHURA Biosciences Inc (HURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HURA Stock Price, Quote & Chart - ChartMill
TuHURA Biosciences, Inc. Files Form 8-K with Nasdaq: Corporate Information, Address, and Key Details - Minichart
TuHURA Biosciences Inc (HURA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TuHURA Biosciences Inc (HURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TuHURA Biosciences Inc (HURA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TuHURA Sets 2026 Virtual Annual Meeting, Proposal Deadlines - TipRanks
Shareholder deadlines set for TuHURA (NASDAQ: HURA) 2026 meeting - Stock Titan
TuHURA Biosciences Inc (HURA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TuHURA Biosciences Inc (HURA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TuHURA Biosciences Inc (HURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TuHURA Biosciences Inc (HURA) Institutional Confidence - TradingKey
TuHURA Biosciences Inc (HURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Citizens reiterates TuHURA Biosciences stock rating on AML progress By Investing.com - Investing.com Canada
HURA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEstimate Revision Count - newsline.com
TuHURA Biosciences (HURA) Rallies 2.8% as Biotech Stock Tests Key Resistance Near $2.50Inside Day Breakout - newsline.com
TuHURA Biosciences (NASDAQ:HURA) files IND for TBS-2025 - grafa.com
TuHURA files IND for TBS-2025 in blood cancer study By Investing.com - Investing.com South Africa
TuHURA files IND for TBS-2025 in blood cancer study - Investing.com
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers - Moomoo
TuHURA Biosciences Q1 2026 Earnings: EPS Misses Estimates, Stock Rises Despite Wider Loss - newsline.com
HURA Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Stage; Stock Gains 5.29%Margin Expansion Trends - newsline.com
TuHURA Biosciences Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Risk Report - newsline.com
TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Miss Highlights Pre-Revenue Biotech's Expense Management ChallengesSurprise Factor Analysis - newsline.com
TuHURA Biosciences Inc. (HURA) Shows Modest Recovery, Tests Key Resistance Near $2.18MACD Signal Stocks - dars.gov.et
TuHURA Biosciences, Inc. Financial Disclosures & SEC Filings - TradingView
TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseMargin Improvement Report - newsline.com
TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Misses Estimates, Stock Slides on Higher Cash Burn and Pre-Revenue StatusGuidance Revision Trend - dars.gov.et
HURA News | TUHURA BIOSCIENCES INC (NASDAQ:HURA) - ChartMill
TuHURA Biosciences, Inc. Files Form 8-K with Nasdaq Listing Details and Company Information - Minichart
TuHURA Biosciences Draws on New $50M Credit Facility - TipRanks
2.64%
大文字化:
|
ボリューム (24 時間):